Sarah Cheney

Health Care Policy Intern

Overview

Sarah Cheney supports Crowell Health Solutions, a strategic consulting firm affiliated with Crowell & Moring, to help clients pursue and deliver innovative alternatives to the traditional approaches of providing and paying for health care, including through digital health, health equity, and value-based health care. She is a healthcare policy intern in the Washington, D.C. office.

Prior to joining Crowell Health Solutions, Sarah worked at a government affairs and intelligence company where she provided healthcare policy consulting services to clients. As an associate consultant, she led regulatory compliance projects for clients interested in drug affordability and transparency. She also monitored legislative updates to public and private insurance options related to coverage, expansion, fraud, and abuse. Sarah also worked as a Policy Analyst under Wisconsin Governor Tony Evers’ Advisory Council on Equity and Inclusion. She graduated from the University of Wisconsin-Madison with a Bachelor’s of Science in Legal Studies and is currently a Master of Public Policy student at The George Washington University.

Sarah's Insights

Client Alert | 2 min read | 08.04.25

FDA Announces Availability of ICH Draft Guidance on Inclusion of Pregnant and Breastfeeding Women in Clinical Trials

On Monday, July 21, 2025, the Food and Drug Administration (FDA) issued draft guidance entitled “E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials” from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The guidance is currently in Step 2 of the ICH process and open for public comment until September 19, 2025....

Sarah's Insights

Client Alert | 2 min read | 08.04.25

FDA Announces Availability of ICH Draft Guidance on Inclusion of Pregnant and Breastfeeding Women in Clinical Trials

On Monday, July 21, 2025, the Food and Drug Administration (FDA) issued draft guidance entitled “E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials” from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The guidance is currently in Step 2 of the ICH process and open for public comment until September 19, 2025....